Explore the vast range of titles available.

A study conducted by Santoshkumar et al. on diabetic hyperlipidemic rats showed a significant reduction in serum TC at the end of 4 weeks in Group IV and Group V rats who were given turmeric in a dose of 300 mg/kg and 500 mg/kg body weight, respectively. [15] Curcumin reduces TC level in the liver along with an increase of a-tocopherol level in rat plasma, suggesting in vivo interaction between curcumin and a-tocopherol that may increase the bioavailability of Vitamin E and decrease cholesterol levels. A study conducted by Santoshkumar et al. on diabetic hyperlipidemic rats showed a significant reduction in serum TG level at the end of 4 weeks in Group IV and Group V rats who were given turmeric in a dose of 300 mg/kg and 500 mg/kg body weight, respectively. Efficacy and Safety of Turmeric and Curcumin in Lowering Blood Lipid Levels in Patients with Cardiovascular Risk Factors: A Meta-analysis of Randomized Controlled Trials.

[...]they are widely used as hypolipidemic agents in treating dyslipidemia and preventing the occurrences of atherosclerosis and coronary heart diseases. [...]there has been a continuous search for a better alternative to NSAID, which will suppress the symptoms of pain as well as will be well tolerated in the body without showing much adverse effects. [...]the present study had been designed for exploring the analgesic potential of atorvastatin and simvastatin in Wistar rats, which may widen the therapeutic horizon for the said agents. [...]simvastatin had a better analgesic property than that of atorvastatin and was found to be comparable with that of aspirin.